Cargando…
Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy
Transition metal dichalcogenides (TMDCs) are categorized as novel two-dimensional (2D) nanomaterials with unique physical and chemical properties, bearing varied applications in medical and materials sciences. However, only a few works report the application of TMDCs for gene therapy in cancer treat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170332/ https://www.ncbi.nlm.nih.gov/pubmed/30324083 http://dx.doi.org/10.7150/ntno.27308 |
_version_ | 1783360629521776640 |
---|---|
author | Yin, Feng Anderson, Tommy Panwar, Nishtha Zhang, Kang Tjin, Swee Chuan Ng, Beng Koon Yoon, Ho Sup Qu, Junle Yong, Ken-Tye |
author_facet | Yin, Feng Anderson, Tommy Panwar, Nishtha Zhang, Kang Tjin, Swee Chuan Ng, Beng Koon Yoon, Ho Sup Qu, Junle Yong, Ken-Tye |
author_sort | Yin, Feng |
collection | PubMed |
description | Transition metal dichalcogenides (TMDCs) are categorized as novel two-dimensional (2D) nanomaterials with unique physical and chemical properties, bearing varied applications in medical and materials sciences. However, only a few works report the application of TMDCs for gene therapy in cancer treatment. Here, we engineer a multi-gene delivery system based on functionalized monolayer MoS(2), which can co-deliver HDAC1 and KRAS small interfering RNAs (siRNAs) to Panc-1 cancer cells for combinational cancer therapy. The synergistic effect of gene silencing therapy and NIR phototherapy is demonstrated by inhibition of both genes, in vitro cell growth rate, and in vivo tumor volume growth rate, exemplifying pre-eminent anticancer efficacy. This anti-tumor effect is a result of the photothermal effect of MoS(2) induced by NIR excitation and inactivation of HDAC1 and KRAS genes, which consequently bring about apoptosis, inhibit migration, and induce cell cycle arrest in the treated Panc-1 cells. Moreover, good biocompatibility and reduced cytotoxicity of MoS(2)-based nanocarriers enable their metabolism within in vitro and in vivo mouse models over a prolonged duration without any evident ill-effects. In summary, we demonstrate the promising potential of low-toxicity, functionalized MoS(2) nanocarriers as a biocompatible gene delivery system for in vivo pancreatic adenocarcinoma therapy. |
format | Online Article Text |
id | pubmed-6170332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-61703322018-10-15 Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy Yin, Feng Anderson, Tommy Panwar, Nishtha Zhang, Kang Tjin, Swee Chuan Ng, Beng Koon Yoon, Ho Sup Qu, Junle Yong, Ken-Tye Nanotheranostics Research Paper Transition metal dichalcogenides (TMDCs) are categorized as novel two-dimensional (2D) nanomaterials with unique physical and chemical properties, bearing varied applications in medical and materials sciences. However, only a few works report the application of TMDCs for gene therapy in cancer treatment. Here, we engineer a multi-gene delivery system based on functionalized monolayer MoS(2), which can co-deliver HDAC1 and KRAS small interfering RNAs (siRNAs) to Panc-1 cancer cells for combinational cancer therapy. The synergistic effect of gene silencing therapy and NIR phototherapy is demonstrated by inhibition of both genes, in vitro cell growth rate, and in vivo tumor volume growth rate, exemplifying pre-eminent anticancer efficacy. This anti-tumor effect is a result of the photothermal effect of MoS(2) induced by NIR excitation and inactivation of HDAC1 and KRAS genes, which consequently bring about apoptosis, inhibit migration, and induce cell cycle arrest in the treated Panc-1 cells. Moreover, good biocompatibility and reduced cytotoxicity of MoS(2)-based nanocarriers enable their metabolism within in vitro and in vivo mouse models over a prolonged duration without any evident ill-effects. In summary, we demonstrate the promising potential of low-toxicity, functionalized MoS(2) nanocarriers as a biocompatible gene delivery system for in vivo pancreatic adenocarcinoma therapy. Ivyspring International Publisher 2018-08-25 /pmc/articles/PMC6170332/ /pubmed/30324083 http://dx.doi.org/10.7150/ntno.27308 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Yin, Feng Anderson, Tommy Panwar, Nishtha Zhang, Kang Tjin, Swee Chuan Ng, Beng Koon Yoon, Ho Sup Qu, Junle Yong, Ken-Tye Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy |
title | Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy |
title_full | Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy |
title_fullStr | Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy |
title_full_unstemmed | Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy |
title_short | Functionalized MoS(2) Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy |
title_sort | functionalized mos(2) nanosheets as multi-gene delivery vehicles for in vivo pancreatic cancer therapy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170332/ https://www.ncbi.nlm.nih.gov/pubmed/30324083 http://dx.doi.org/10.7150/ntno.27308 |
work_keys_str_mv | AT yinfeng functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT andersontommy functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT panwarnishtha functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT zhangkang functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT tjinsweechuan functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT ngbengkoon functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT yoonhosup functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT qujunle functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy AT yongkentye functionalizedmos2nanosheetsasmultigenedeliveryvehiclesforinvivopancreaticcancertherapy |